Myasthenia Gravis Panel 2
The Myasthenia Gravis Panel 2 test contains 1 test with 3 biomarkers.
Myasthenia Gravis is a neurological disorder characterized by a decrease in acetylcholine receptors. Patients exhibit skeletal muscle weakness and fatigability. Approximately 80% of patients with Myasthenia Gravis, excluding ocular involvement only, have detectable acetylcholine receptor antibody.
Acetylcholine Receptor Binding Antibody
Acetylcholine Receptor Blocking Antibody
Acetylcholine Receptor Modulating Antibody
- $588.74
- $374
- Save: 36.47%
The following is a list of what is included in the item above. Click the test(s) below to view what biomarkers are measured along with an explanation of what the biomarker is measuring.
Myasthenia Gravis Panel 2 #10104
3 Biomarkers - Process Time*: Average 5 to 6 days
Also known as: Anti-striated Muscle Antibody
Biomarkers 3
Acetylcholine Receptor
Acetylcholine Receptor
Acetylcholine Receptor
*Process times are an estimate and are not guaranteed. The lab may need additional time due to weather, holidays, confirmation/repeat testing, or equipment maintenance.